These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28445552)

  • 1. Correction: Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.
    Li H; Li L; Gu J; Li Y; Chen X; Yang D
    PLoS One; 2017; 12(4):e0176806. PubMed ID: 28445552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Prevalence and associated risk factors for mental health problems among patients with polycystic ovary syndrome in Bangladesh: A nationwide cross-sectional study.
    Hasan M; Sultana S; Sohan M; Parvin S; Rahman MA; Hossain MJ; Rahman MS; Islam MR
    PLoS One; 2024; 19(5):e0304879. PubMed ID: 38820325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.
    Li H; Li L; Gu J; Li Y; Chen X; Yang D
    PLoS One; 2016; 11(11):e0167036. PubMed ID: 27902723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Metabolic and Body Composition Risk Factors Associated with Metabolic Syndrome in a Cohort of Women with a High Prevalence of Cardiometabolic Disease.
    PLOS ONE Staff
    PLoS One; 2016; 11(10):e0165215. PubMed ID: 27749927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Postpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational Study.
    Govorov I; Löfgren S; Chaireti R; Holmström M; Bremme K; Mints M
    PLoS One; 2017; 12(2):e0172185. PubMed ID: 28182756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.
    PLOS ONE Staff
    PLoS One; 2016; 11(12):e0168319. PubMed ID: 27936068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.
    Wolkewitz M; Schumacher M
    PLoS One; 2017; 12(4):e0175660. PubMed ID: 28384330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Women with polycystric ovary syndrome have a higher frequency of metabolic syndrome regardless of body mass index].
    Melo AS; Macedo CS; Romano LG; Ferriani RA; Navarro PA
    Rev Bras Ginecol Obstet; 2012 Jan; 34(1):4-10. PubMed ID: 22358341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria.
    Day F; Karaderi T; Jones MR; Meun C; He C; Drong A; Kraft P; Lin N; Huang H; Broer L; Magi R; Saxena R; Laisk T; Urbanek M; Hayes MG; Thorleifsson G; Fernandez-Tajes J; Mahajan A; Mullin BH; Stuckey BGA; Spector TD; Wilson SG; Goodarzi MO; Davis L; Obermayer-Pietsch B; Uitterlinden AG; Anttila V; Neale BM; Jarvelin MR; Fauser B; Kowalska I; Visser JA; Andersen M; Ong K; Stener-Victorin E; Ehrmann D; Legro RS; Salumets A; McCarthy MI; Morin-Papunen L; Thorsteinsdottir U; Stefansson K; ; Styrkarsdottir U; Perry JRB; Dunaif A; Laven J; Franks S; Lindgren CM; Welt CK
    PLoS Genet; 2019 Dec; 15(12):e1008517. PubMed ID: 31805045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Cardiorespiratory Fitness, Sedentary Behaviour and Physical Activity Are Independently Associated with the Metabolic Syndrome, Results from the SCAPIS Pilot Study.
    Ekblom Ö; Ekblom-Bak E; Rosengren A; Hallsten M; Bergström G; Börjesson M
    PLoS One; 2018; 13(5):e0197801. PubMed ID: 29787585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Medication reconciliation on discharge in a tertiary care Riyadh Hospital: An observational study.
    Alanazi AS; Awwad S; Khan TM; Asdaq SMB; Mohzari Y; Alanazi F; Alrashed A; Alamri AS; Alsanie WF; Alhomrani M; AlMotairi M
    PLoS One; 2023; 18(5):e0286177. PubMed ID: 37200268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome.
    Walch K; Grimm C; Nagele F; Huber J; Wölfler M; Vytiska-Binstorfer E; Unfried G; Hefler L
    Acta Obstet Gynecol Scand; 2006; 85(7):869-73. PubMed ID: 16817088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Estrogen Signalling and the Metabolic Syndrome: Targeting the Hepatic Estrogen Receptor Alpha Action.
    Matic M; Bryzgalova G; Gao H; Antonson P; Humire P; Omoto Y; Portwood N; Pramfalk C; Efendic S; Berggren PO; Gustafsson JÅ; Dahlman-Wright K
    PLoS One; 2019; 14(6):e0217526. PubMed ID: 31216317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study.
    Hamaguchi T; Tayama J; Suzuki M; Nakaya N; Takizawa H; Koizumi K; Amano Y; Kanazawa M; Fukudo S
    PLoS One; 2020; 15(12):e0244465. PubMed ID: 33332457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Metabolic syndrome in Xinjiang Kazakhs and construction of a risk prediction model for cardiovascular disease risk.
    Mao L; He J; Gao X; Guo H; Wang K; Zhang X; Yang W; Zhang J; Li S; Hu Y; Mu L; Yan Y; Ma J; Ding Y; Zhang M; Liu J; Ma R; Guo S
    PLoS One; 2019; 14(1):e0210907. PubMed ID: 30629704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study.
    PLOS ONE Staff
    PLoS One; 2017; 12(2):e0172417. PubMed ID: 28192526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Random-Effects, Fixed-Effects and the within-between Specification for Clustered Data in Observational Health Studies: A Simulation Study.
    Dieleman JL; Templin T
    PLoS One; 2016; 11(5):e0156508. PubMed ID: 27218254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.
    Baranova A; Tran TP; Birerdinc A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Apr; 33(7):801-14. PubMed ID: 21251033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.